Targeting the CMKLR1‐Mediated Signaling Rebalances Immunometabolism State in Middle‐Age Testicular Macrophages
Advanced Science · 2026
DOI: 10.1002/advs.202515166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Zhendong Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-Of-Concept Center, Shenzhen Institutes of A…. Hauptthemen laut MEDLINE: Macrophages, Testis, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Shenzhen Medical Research Fund, National Natural Science Foundation of China.
Abstract (Originalsprache)
Age‐related male hypogonadism is often associated with obesity‐related metabolic disorders and impaired regulation of the testicular anti‐inflammatory microenvironment. However, how adipose‐mediated signals intersect with local testicular immunity remains unclear. In this study, single‐cell RNA sequencing (scRNA‐seq) of human and mouse testes identified a conserved CD206 Lo MHCII Hi macrophage subset, which undergoes CMKLR1‐mediated metabolic reprogramming toward glycolysis and pro‐inflammatory state during middle age. This immunometabolic shift is further found to impair spermatogenesis. CMKLR1 is identified as a viable target in vivo for restoring immunometabolic balance in aging testes. Systemic administration of a newly developed CMKLR1 antagonist peptide (P12C5) or non‐pharmacological intervention such as high‐intensity interval training (HIIT) rescued spermatogenesis in middle‐aged humans and mice, and reversed the pro‐inflammatory immunometabolic phenotype in testicular macrophages. Together, these findings validate CMKLR1 as a key modulator of testicular immunometabolism and a therapeutic target for mitigating age‐related immunometabolic dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Metabolic Health, Shenzhen Metabolism and Reproductive Targeted Delivery Proof-Of-Concept Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong,…
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Health Sciences Institute of China Medical University, Shenyang, Liaoning, China.
- Medical Research Center, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
- Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
- Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen, Guangdong, 518107, China.
ORCID-Profile: Zhendong Zhu, Jia Tang, Jian V Zhang
Förderung
- National Key R&D Program of China
- Shenzhen Medical Research Fund
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Program
- Research Foundation of Guangdong Provincial Reproductive Science Institute
- Shenzhen Key Laboratory of Metabolic Health
- Sino-European Center of Biomedicine and Health
Zitieren
APA
Zhu, Z., Du, F., Liu, Y., Yang, J., Ge, L., Xiao, T., Li, M., Chen, J., Tang, J., Yang, Y., & Zhang, J. V. (2026). Targeting the CMKLR1‐Mediated Signaling Rebalances Immunometabolism State in Middle‐Age Testicular Macrophages. Advanced Science. https://doi.org/10.1002/advs.202515166
Vancouver
Zhu Z, Du F, Liu Y, Yang J, Ge L, Xiao T, et al. Targeting the CMKLR1‐Mediated Signaling Rebalances Immunometabolism State in Middle‐Age Testicular Macrophages. Advanced Science. 2026. doi:10.1002/advs.202515166
BibTeX
@article{Zhu2026,
author = {Zhu, Zhendong and Du, Feifei and Liu, Yang and Yang, Jinchunzi and Ge, Lei and Xiao, Tianxia and Li, Mengxia and Chen, Jie and Tang, Jia and Yang, Yali and Zhang, Jian V},
title = {Targeting the CMKLR1‐Mediated Signaling Rebalances Immunometabolism State in Middle‐Age Testicular Macrophages},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202515166}
}
EUVIMED